Enhanced Recovery With Liposomal Bupivacaine in Orthognathic Surgery

Status unconfirmed · Phase 4

Conditions studied: Pain, Postoperative

In brief

The proposed study design is a prospective, clinical trial comparing control group patients (CG; ncg = 30) that will undergo conventional perioperative management without an ERAS protocol and standard bupivacaine intraoperative nerve block to randomized treatment group patients that will receive an intraoperative V2 trigeminal nerve block using LB (TG; ntg = 30).

Key facts

Study ID

NCT03844451

Run by

University of Texas at Austin

People needed

75

Starts

2019-05-17

Expected to finish

2019-11-01

Last updated by the study team

2019-02-18

Who can join

Age: 15 and older, up to 25. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• All patients undergoing orthognathic surgery at Dell Children's Medical Center will be intended for inclusion in the study.

You may not qualify if…

• Only those patients with insufficient data in their medical records or contraindications to the administration of liposomal bupivacaine (hepatic disease or allergy to amide local anesthetics) will be excluded from the study.

Where it is running

• Dell Children's Medical Center — Austin, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.